Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H12F2N4 |
InChIKeyLBPYNNJXARHGAG-UHFFFAOYSA-N |
CAS Registry381168-77-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 14 Nov 2013 |





